The effects of bone resorption inhibitors on the growth plate and proximal tibial metaphysis of rats: Clinical implications

Orthopedics

Volumn 21, Issue 2, 1998, Pages 195-199

  Pazzaglia, Ugo E ^a   Andrini, Luca ^a   Leutner, Monica ^a   Di Nucci, Amalia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMINOHEXANEDIPHOSPHONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; SALCATONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MINERAL; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CONTROLLED STUDY; DRUG EFFECT; GROWTH PLATE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METAPHYSIS; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA; TRABECULAR BONE;

ANIMALS; BONE RESORPTION; CALCITONIN; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; EVALUATION STUDIES; GROWTH PLATE; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0031952483     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pazzaglia UE, Zatti G, Di Nucci A, Coci A, Cherubino P. Experimental model in vivo for quantitative assessment of bone resorption inhibition. J Orthop Res. 1993; 11:892-896.
2. Cowell HR, Hunziker EB, Resemberg L. The role of hypertrophic chondrocytes in endochondral ossification and in the development of secondary centers of ossification. J Bone Joint Surg Am. 1987; 69:159-161.
3. Hunziker EB, Schenk RK, Cruz-Orive LM. Quantitation of chondrocytes performance in growth plate cartilage during longitudinal bone growth. J Bone Joint Surg Am. 1978; 69:162-173.
4. Pratt CWM. The significance of the 'perichondrial zone' in a developing long bone of the rat. J Anat. 1959; 93:110-122.
5. Shapiro F, Holtrop ME, Glimcher MJ. Organization and cellular biology of perichondrial ossification groove of Ranvier. A morphological study in rabbits. J Bone Joint Surg Am. 1977; 59:703-723.
6. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Biphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990; 85:456-461.
7. 2MBP-coated bone. Bone and Mineral. 1989; 6:33-43.
8. Schenk R, Eggli P, Fleisch H, Rosini S. Quantitative morphometric evaluation of the inibitory activity of a new aminobiphosphonates on bone resorption in the rat. Calcif Tissue Int. 1986; 38:342-349.
9. Pazzaglia UE, Zatti G, Rolla P, Di Nucci A. Reversibility of the inhibitory effect of salmon calcitonin on bone resorption in rats. Acta Orthop Scand. 1994; 65:142-146.
10. Flanagan AM, Chambers TJ. Inhibition of bone resorption biphosphonates: interactions between biphosphonates, osteoclasts, and bone. Calcif Tissue Int. 1991; 49:407-415.
11. Miller SC, Jee WSS, Kimmel DB, Woodbury L. Ethane-1-hydroxy-1,1diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei. Calcif Tissue Res. 1977; 22:243-252.
12. 2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia. Calcif Tissue Res. 1977; 23:207-214.
13. 2MBP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res. 1973; 11:196-214.
14. Fleisch H. Biphosphonates: mechanism of action and clinical applications. In: Peck WA, ed. Calcified Tissue International. Amsterdam: Excepta Medica; 1983; 1:319-357.
15. Fleisch H. Biphosphonates in osteoporosis: an introduction. Osteoporos Int. 1993; (suppl 3):S3-S5.
16. Meerten EL, Kroon HM, Papapoulus SE. Epi- and metaphyseal changes in children caused by administration of biphosphonates. Radiology. 1992; 184:249-254.
17. Pazzaglia UE, Beluffi G, Ravelli A, Zatti G, Martini A. Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva. Pediatr Radiol. 1993; 23:459-462.
18. Rogers JG, Dorst JP, Geho WB. Use and complication of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva. J Pediatr. 1977; 91:1011-1014.